Sialorrhea

21 registered clinical trials studyying Sialorrhea.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Effect of SCS Technique on Oromotor Skills in Children With CP NCT07516860	Cairo University	N/A
Completed	Pharmacokinetics of Atropine Oral Gel NCT05164367	University of Utah	EARLY_Phase 1
Withdrawn	Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric Subjects NCT05097079	Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC	Phase 3
Completed	Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy NCT06101160	Cairo University	—
Unknown	Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus NCT04873115	Proveca Pharma Limited	Phase 4
Withdrawn	Safety and Efficacy of Cryoablation in Management of Sialorrhea in Patients With Neurological Disorders NCT03704168	Dean Nakamoto	N/A
Unknown	Ipratropium Bromide Spray as Treatment for Sialorrhea in Children NCT03747536	London Health Sciences Centre	Phase 2
Completed	Prevalence of Sialorrhea in Patients Treated With Clozapine NCT04197037	Parc de Salut Mar	—
Unknown	Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease NCT02382198	Ottawa Hospital Research Institute	Phase 2
Completed	Clozapine-induced Hypersalivation - Feasibility Trial NCT02613494	Mersey Care NHS Trust	Phase 1 / Phase 2
Completed	Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults NCT02610868	Supernus Pharmaceuticals, Inc.	Phase 3
Completed	Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment NCT01994109	Supernus Pharmaceuticals, Inc.	Phase 3
Completed	Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism NCT01653132	Beth Israel Deaconess Medical Center	Phase 2
Completed	Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea NCT01551940	Hospices Civils de Lyon	Phase 2
Unknown	Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebra NCT01489904	Hospital Vall d'Hebron	Phase 2 / Phase 3
Completed	Oral Health Literacy Tailored Communication NCT01118143	University of Tromso	N/A
Completed	Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine Sedation NCT01191398	Craig J. Huang	N/A
Completed	Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases NCT02425176	University of Malaya	Phase 2 / Phase 3
Completed	Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to S NCT00491894	Shionogi	Phase 3
Completed	Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS NCT00125203	The University of Texas Health Science Center at San Antonio	Phase 2 / Phase 3
Completed	FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey NCT00683891	Azur Pharma, Inc	—